| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/20/2002 | US20020076453 Angiotensin I-converting enzyme inhibitory substance |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076381 Novel compositions for use in embolizing blood vessels |
| 06/20/2002 | DE10154224A1 Composition for treating cardiac insufficiency, containing a construct that expresses basic helix-loop-helix transcription factors |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | DE10061876A1 Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Arylated furan and thiophenecarboxamides, processes for their preparation, their use as a medicine and pharmaceutical compositions containing them |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | DE10059838A1 Arzneimittelzubereitung mit anti-arteriosklerotischer Wirkung The pharmaceutical preparation with anti-atherosclerotic effect |
| 06/20/2002 | DE10059418A1 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, meta-substituted Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | CA2431800A1 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2431173A1 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/20/2002 | CA2431172A1 Nmda receptor antagonist pharmaceutical compositions |
| 06/20/2002 | CA2431095A1 Arylated furan- and thiophenecarboxamides, with potassium channel-blocking action |
| 06/20/2002 | CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430415A1 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
| 06/20/2002 | CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | CA2429839A1 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/20/2002 | CA2427271A1 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/19/2002 | EP1215587A2 Adenosine monophosphate deaminase crystal structure |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214452A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214439A2 Smooth muscle cell promoter and uses thereof |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214408A1 Ribozymes used for restenosis prevention |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214350A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 06/19/2002 | EP1214346A1 A novel angiogenesis inhibitor |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214335A1 Gamma-carboxyglutamate containing conopeptides |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214323A1 Indoloazepines as vasopressin receptor antagonists |
| 06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
| 06/19/2002 | EP1214320A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 06/19/2002 | EP1214307A1 4-oxybenzopyran derivative |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214287A1 Amides as inhibitors for pyruvate dehydrogenase |
| 06/19/2002 | EP1214100A2 Method for determining viability of a myocardial segment |
| 06/19/2002 | EP1214091A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214085A2 An antioxidant preparation based on plant extracts for the treatment of circulation and chronic degenerative problems and of hypertension |
| 06/19/2002 | EP1214084A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/19/2002 | EP1214077A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 06/19/2002 | EP1214057A1 Vascular coating composition |
| 06/19/2002 | EP1214019A1 Radioactive graft or cuff |
| 06/19/2002 | EP1105395B1 Photocyclized rapamycins |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0877750B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 06/19/2002 | CN1354744A Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 06/19/2002 | CN1354742A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 06/19/2002 | CN1354677A Topical compositions for prostaglandin E1 delivery |
| 06/19/2002 | CN1354676A Amnotetralin derivative for therapy of cardiovascular diseases |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354665A Sustained release ranolazine formulations |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354622A Prostaglandin compound, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 06/19/2002 | CN1354004A Chinese medicine composition for curing sick sinus syndrome |
| 06/19/2002 | CN1354003A Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| 06/19/2002 | CN1353998A Chinese medicine preparation for curing hemorrhoid |
| 06/19/2002 | CN1353989A Medicine for curing angiopathy |
| 06/19/2002 | CN1353981A Quick-acting aerosol for resisting angina cordis and its preparation method |
| 06/19/2002 | CN1086295C External used medicinal liquor |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407093 (3,4-dihydro-2h-benzothiopyran-4-yl)-homopiperazine derivatives; antiischemic agents; alzheimer*s and parkinson*s disease, aids related dementia, multiple sclerosis, amyotrophic lateral sclerosis |
| 06/18/2002 | US6407076 Adenosine analogues and related method of treatment |
| 06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
| 06/18/2002 | US6406694 Anti-CCR2 antibodies |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/18/2002 | CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
| 06/14/2002 | WO2001041709A2 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2393722A1 Methods for treating cell death diseases and inflammation |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |